A service of StreetInsider.com
Welcome

Most Popular

AAPL 223.27
C 3.98
GOOG 559.17
BAC 16.79
RIMM 73.06

Recently Added

WWIN 6.25
CCLTF 9.20
KCAP 5.35
NWM 0.01
CNYD 13.19

Gaining Speed

CNYD 13.19
KCAP 5.35
CCLTF 9.20
FGEXF 0.35
GRU 5.06
9.06 +0.07 (0.76%) SCR

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:9.06 Change:+0.07 (0.76%) Prev Close:8.99 Open: 9.19 Days Range:9.00 – 9.35 52 Week Range: 4.80 - 10.03 Volume:30672 P/E: N/A
EPS:0.00

Member Comments

No member comments available for SCR


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 03/22/10

Recent Alert on 03/22/10 at 7:16am
Simcere Pharma (SCR) Announces Completion of Endostar Phase IV

Simcere Pharmaceutical Group (NYSE: SCR) announced today the successful completion of Endostar Phase IV clinical study at a conference in Beijing dedicated to this study. The New Drug Research Institute of Cancer Hospital, the Chinese Academy of... Read More

Recent Alert on 03/22/10 at 7:16am
Simcere Pharma (SCR) Announces Completion of Endostar Phase IV
Recent Alert on 03/16/10 at 7:29am
Simcere Pharma (SCR) Posts Q4 EPS of $0.05, Misses Views
Recent Alert on 03/15/10 at 3:48pm
Trading Radar for 03/16: Discover Financial (DFS), AMBAC Financial (ABK), General Steel (GSI), Ariad Pharma (ARIA) Report
Recent Alert on 01/22/10 at 8:16am
Oppenheimer Downgrades Simcere Pharmaceutical (SCR) to Perform

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

No Recent SEC Filings Available

View AllRecent Blog Posts

Blog Posts on 03/22/10 at 4:03am
40 Chinese Stocks Trading Under $10
Blog Posts on 02/14/10 at 9:16am
China Biotech Week in Review
Blog Posts on 02/12/10 at 4:48am
Simcere Wins OK for Flu Drug Relenza
Blog Posts on 02/11/10 at 1:36pm
Drug Stocks Offer Big Yields, Long-Term Investment Opportunities
Blog Posts on 12/03/09 at 6:27am
Simcere Shuts Down Production in Rabies Vaccine Subsidiary over Quality Control